GNRH1 and ovarian hyperstimulation syndrome: A GnRH antagonist (GnRH-ant) cycle followed by a GnRH-a trigger and a “freeze all” policy has proven to be the most effective strategy against OHSS development [17], significantly changing ovarian stimulation and transfer policies worldwide, particularly for women deemed to be at high risk of OHSS.